KENNET AND AVON MEDICAL PARTNERSHIP
GEORGE LANE, MARLBOROUGHCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 303 | 334 | 90.7% | |
CHD 9 | 2006 | 329 | 355 | 92.7% | |
CHD 9 | 2007 | 311 | 333 | 93.4% | |
CHD 9 | 2008 | 298 | 322 | 92.5% | |
CHD 9 | 2009 | 289 | 319 | 90.6% | |
CHD 9 | 2010 | 282 | 314 | 89.8% | |
CHD 9 | 2011 | 274 | 301 | 91.0% | |
CHD 9 | 2012 | 266 | 297 | 89.6% | |
CHD 9 | 2013 | 267 | 295 | 90.5% | |
CHD005 | 2014 | 281 | 301 | 93.4% | |
CHD005 | 2015 | 283 | 288 | 98.3% | |
CHD005 | 2016 | 277 | 280 | 98.9% | |
CHD005 | 2017 | 294 | 296 | 99.3% | |
CHD005 | 2018 | 464 | 513 | 90.4% | |
CHD005 | 2019 | 482 | 492 | 98.0% | |
CHD005 | 2020 | 491 | 509 | 96.5% | |
CHD005 | 2021 | 502 | 551 | 91.1% | |
CHD005 | 2022 | 529 | 550 | 96.2% | |
CHD005 | 2023 | 544 | 551 | 98.7% |